Navigation Links
SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
Date:6/5/2013

SAN JOSE, Calif., June 5, 2013 /PRNewswire/ -- SI-BONE, Inc. (San Jose, California), a medical device company that is pioneering the use of a minimally invasive surgical (MIS) device to fuse the sacroiliac (SI) joint, announced today the publication of the iFuse Implant System's® postmarket surveillance safety data for the first 5,319 patients treated.  The paper entitled: Analysis of the postmarket complaints database for the iFuse SI Joint Fusion System: a minimally invasive treatment for degenerative sacroiliitis and sacroiliac joint disruption, was published in Medical Devices: Evidence and Research on May 28, 2013.  The purpose of the study was to provide an analysis of postmarket surveillance complaints by evaluating SI-BONE's postmarket complaints database.  The analysis, which covers a 4-year period from April 2009 to January 2013 and includes 5,319 patients, revealed an overall postmarket complaint rate of 3.8% including a total revision rate of 1.8% and a late postoperative revision rate of 0.6%.  Revisions in the late postoperative period were performed to treat symptom recurrence or for continued pain of undetermined etiology at a median 279 days post-op.1  These rates are consistent with two previously published case series of the iFuse Implant System that reported 1-2 years post-treatment revision rates of 8% and 0%.2,3    "We are extremely proud of the safety and clinical effectiveness record that surgeons have demonstrated with the iFuse procedure.  Our core focus as a company is patient safety and procedure effectiveness at an overall reduced cost to the healthcare system.  We understand that additional clinical trials reporting on clinical outcomes will be published this year," said Jeffrey Dunn , President and CEO of SI-BONE.

(Logo:

SOURCE SI-BONE, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. SI-BONE, Inc. Announces Spring Society Meeting Attendance
2. Pressure BioSciences Announces Core Technology Breakthrough
3. MGT Capital Investments, Inc. Announces Sale of Medicsight Patents
4. Kinex Announces that the US FDA Allows their IND to Begin KX02 Clinical Trials
5. Cheetah Medical Announces New Management Team
6. Accelerate Diagnostics Announces Plans For Rights Offering To Stockholders
7. Array BioPharma Announces Proposed Public Offering of Convertible Debt
8. Gulf Coast Spine Care Announces New Neck Pain Treatments
9. HPN Announces Team POWERDOT Wins $500,000 As Current Leader
10. Boston Scientific Announces Collaboration with Pelvic Floor Disorders Network to Study Treatment Strategies for Uterine Prolapse
11. Ferring Pharmaceuticals Inc. Announces $1M Donation to the Alliance for Fertility Preservation, a Newly Formed Charitable Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... ANGELES , SINGAPORE, and TOKYO , ... announced that it has appointed Roger Crystal , ... most recently served in the Global Business Development Product ... "Roger,s experience in developing business strategy and ... valuable as we continue to partner with biotechnology and ...
(Date:7/28/2014)... 28, 2014  ANI Pharmaceuticals, Inc. (NASDAQ: ... release its second quarter and year-to-date 2014 financial results ... the U.S. financial markets. The earnings press release will ... Company,s website, www.anipharmaceuticals.com . Arthur ... Charlotte C. Arnold , Vice President and Chief ...
(Date:7/28/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Results and Highlights Conference CallWhen:Monday, August 4 at 10:30 ... on the Internet. Simply log onto our website listed ... live event, a replay of the webcast will be ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
Breaking Medicine Technology:ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... Nov. 12 Based on its recent analysis ... & Sullivan presents Fovia, Inc. with the 2009 ... Innovation of the Year. Fovia is being recognized ... platform that offers unrivaled image quality and uncompromised ...
... Corporation (Nasdaq: THOR ), a world leader in ... restore failing hearts, said today that it will webcast ... II Destination Therapy clinical trial that will be presented ... American Heart Association(AHA) Scientific Sessions 2009. , The event ...
Cached Medicine Technology:Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough 2Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough 3Frost & Sullivan Recognizes Fovia for its HDVR(R) Platform - A Disruptive Technology Breakthrough 4
(Date:7/28/2014)... Mitul R. Patel, DDS and concerned ... MGE Management Experts Benefit Dinner May 30, in St. ... Dentists to raise funds for the Improving Youth Literacy ... and Youth Programs across America. The funds raised are ... and audio books to directly tackle illiteracy and help ...
(Date:7/28/2014)... Dr. Alan Xenakis, MD announced today the release ... The new book, DOC X MD Funny Feelings ... telling style with humor and medical accuracy. The book is ... find answers to those age-old questions that most folks are ... Why do mosquitoes bite some and not others? Why do ...
(Date:7/27/2014)... the leader in compression technology and sports medicine, has expanded ... The wrist support features an adjustable velcro strap and provides ... more commonly referred to as tennis elbow and golfers elbow, ... tendons attached to the outside of the elbow. Although this ... the wrist and fingers turn into a tendon that attaches ...
(Date:7/27/2014)... Manufacturers of natural ingredient beauty creams are ... a younger appearance. The Cherry News company has published ... and women explore the availabilities from U.S. retailers at ... in the posted guide on the Cherry News website ... drawback to some natural ingredient formulas is the high ...
(Date:7/27/2014)... of hepatitis E virus (HEV) transmission by blood components ... have HEV in their plasma. The findings, published in ... blood components (eg, red cells, platelets, and fresh frozen ... England. , The study retrospectively screened 225 000 ... Oct, 2012 and Sept, 2013 for HEV RNA. 79 ...
Breaking Medicine News(10 mins):Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 2Health News:Mitul R. Patel, DDS Successfully Attacks a Major Source of Economic Destruction in the Battle Against Illiteracy and Poverty 3Health News:New Book by Alan P. Xenakis, MD Reveals Mind and Body Mysteries 2Health News:Zensah® Releases New Wrist Support 2Health News:Natural Eye Cream Buyer's Guide Published Online at Consumer News Website 2Health News:The Lancet: 1 in 3000 blood donors in England infected with hepatitis E 2
... Roughly 15% of children suffer from migraines, and approximately one-third ... of symptoms that can include weakness, blind spots, and even ... new study soon to be published in The Journal ... children and a heart defect called patent foramen ovale, which ...
... cells in the intestine, which when they mutate can lead ... to combat the effects of those same cancers, the UK ... today. Professor Nick Barker of the Institute of Medical ... identified that the stem cells which are crucial to maintaining ...
... Commons, an initiative of CollabRx, a provider of ... research, announces the publication of a molecular disease ... into molecular subtypes, rather than traditional histological or ... subtype, including specific assays, drugs, and clinical trials. ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, March ... U.S. Food and Drug Administration (FDA) is meeting Wednesday and ... used food dyes and attention-deficit/hyperactivity disorder (ADHD), and if so, ... industry against some parents, public watchdog groups and academics who,ve ...
... HealthDay Reporter , WEDNESDAY, March 30 (HealthDay News) -- ... nursing homes, a new study shows. Researchers say the ... lead to improvements in patient care. Nor does it appear ... in terms of fewer lawsuits. "Nursing homes that are ...
... for Maternal-Fetal Medicine (SMFM) weighed in on today,s FDA ... caproate, also known as 17P. This FDA announcement ... and others regarding the costs of the just-released pharmaceutical ... made by KV Pharmaceuticals, is being sold at $1,500 ...
Cached Medicine News:Health News:Attacking bowel cancer on 2 fronts 2Health News:Researchers publish molecular disease model for melanoma 2Health News:Researchers publish molecular disease model for melanoma 3Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 2Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 3Health News:FDA Panel Examines Possible Links Between Food Dyes, ADHD 4Health News:Lawsuits Aren't Improving Nursing Home Care: Study 2Health News:Lawsuits Aren't Improving Nursing Home Care: Study 3Health News:Lawsuits Aren't Improving Nursing Home Care: Study 4Health News:Society for Maternal-Fetal Medicine commends FDA on makena announcement 2
... the challenge of,controlling costs while handling ... data,management is critical. INFINITY modular,patient monitors ... clinical information,wherever you are in the ... your job easier. You can monitor,your ...
... The biograph 6 offers ... improved disease diagnosis and treatment ... It delivers high-quality PET/CT whole ... 15 minutes. Our comprehensive suite ...
... offers the ultimate PET/CT performance ... treatment in oncology, neurology, and ... whole body scans in less ... suite of clinical applications offers ...
... Duo is a SmartBeam platform providing high-performance ... of the two most clinical sites - ... at a low radiation dose., ,The ... Windows, optimizes productivity and ensures consistant results. ...
Medicine Products: